These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 8691442)

  • 1. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of dynorphin a analogues modified in the address sequence.
    Schlechtingen G; DeHaven RN; Daubert JD; Cassel JA; Chung NN; Schiller PW; Taulane JP; Goodman M
    J Med Chem; 2003 May; 46(11):2104-9. PubMed ID: 12747782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
    Kawasaki AM; Knapp RJ; Kramer TH; Walton A; Wire WS; Hashimoto S; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    J Med Chem; 1993 Mar; 36(6):750-7. PubMed ID: 8096246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.
    Guerrini R; Capasso A; Marastoni M; Bryant SD; Cooper PS; Lazarus LH; Temussi PA; Salvadori S
    Bioorg Med Chem; 1998 Jan; 6(1):57-62. PubMed ID: 9502105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1995 Jun; 38(13):2410-7. PubMed ID: 7608905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
    Meyer JP; Collins N; Lung FD; Davis P; Zalewska T; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1994 Nov; 37(23):3910-7. PubMed ID: 7966152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10.
    Lemaire S; Lafrance L; Dumont M
    Int J Pept Protein Res; 1986 Mar; 27(3):300-5. PubMed ID: 2872177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modification of the basic residues of dynorphin A-(1-13) amide on kappa opioid receptor selectivity and opioid activity.
    Snyder KR; Story SC; Heidt ME; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1992 Nov; 35(23):4330-3. PubMed ID: 1360025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
    Kawasaki AM; Knapp RJ; Kramer TH; Wire WS; Vasquez OS; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
    Story SC; Murray TF; Delander GE; Aldrich JV
    Int J Pept Protein Res; 1992 Aug; 40(2):89-96. PubMed ID: 1359999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues.
    Yoshino H; Nakazawa T; Arakawa Y; Kaneko T; Tsuchiya Y; Matsunaga M; Araki S; Ikeda M; Yamatsu K; Tachibana S
    J Med Chem; 1990 Jan; 33(1):206-12. PubMed ID: 1967312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors.
    Aldrich JV; Zheng QI; Murray TF
    Chirality; 2001; 13(3):125-9. PubMed ID: 11270320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.